IMTX
Price:
$9.38
Market Cap:
$1.08B
Immatics N.V. is a clinical-stage biopharmaceutical firm dedicated to discovering and advancing T-cell receptor (TCR) based immunotherapies aimed at combating cancer, primarily within the United States. Its therapeutic strategy centers on targeted immunotherapies for solid tumors, utilizing two distinct approaches: adoptive cell therapies (ACT) and antibody-like TCR Bispecifics. The company's ACTengine™ portfolio features several candidates in Phase I clinical trials. These include IMA201, designed to recognize melanoma-associated antigens 4 or 8 in solid tumor patients; IMA202, which targets melanoma-associated antigen 1 across various solid tumor types, such as squamous non-small cell lung...[Read more]
Industry
Biotechnology
IPO Date
2018-12-12
Stock Exchange
NASDAQ
Ticker
IMTX
According to Immatics N.V.’s latest financial reports and current stock price. The company's current Enterprise Value is 797.07M. This represents a change of 28.59% compared to the average of 619.86M of the last 4 quarters.
The mean historical Enterprise Value of Immatics N.V. over the last ten years is 511.31M. The current 797.07M Enterprise Value has changed 15.49% with respect to the historical average. Over the past ten years (40 quarters), IMTX's Enterprise Value was at its highest in in the June 2024 quarter at 1.04B. The Enterprise Value was at its lowest in in the March 2018 quarter at 0.
Average
511.31M
Median
512.01M
Minimum
222.43M
Maximum
763.23M
Discovering the peaks and valleys of Immatics N.V. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 178.94%
Maximum Annual Enterprise Value = 763.23M
Minimum Annual Increase = -53.97%
Minimum Annual Enterprise Value = 222.43M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 763.23M | 45.16% |
| 2024 | 525.80M | -6.82% |
| 2023 | 564.26M | 36.68% |
| 2022 | 412.84M | -33.46% |
| 2021 | 620.44M | 178.94% |
| 2020 | 222.43M | -53.97% |
| 2019 | 483.28M | -3.00% |
The current Enterprise Value of Immatics N.V. (IMTX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
617.76M
5-year avg
577.31M
10-year avg
511.31M
Immatics N.V.’s Enterprise Value is less than Inhibrx Biosciences, Inc. (1.20B), less than Enliven Therapeutics, Inc. (2.68B), less than Nektar Therapeutics (1.17B), less than Terns Pharmaceuticals, Inc. (4.25B), less than Tourmaline Bio, Inc. (1.20B), less than Relay Therapeutics, Inc. (2.42B), less than Syndax Pharmaceuticals, Inc. (1.83B), less than Atai Beckley Inc. (1.40B), less than Precigen, Inc. (1.43B), greater than CureVac N.V. (522.95M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 1.20B | $1.35B | |
| 2.68B | $2.81B | |
| 1.17B | $1.16B | |
| 4.25B | $4.77B | |
| 1.20B | $1.23B | |
| 2.42B | $2.59B | |
| 1.83B | $1.62B | |
| 1.40B | $1.44B | |
| 1.43B | $1.34B | |
| 522.95M | $1.05B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Immatics N.V. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Immatics N.V. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Immatics N.V.'s Enterprise Value?
What is the highest Enterprise Value for Immatics N.V. (IMTX)?
What is the 3-year average Enterprise Value for Immatics N.V. (IMTX)?
What is the 5-year average Enterprise Value for Immatics N.V. (IMTX)?
How does the current Enterprise Value for Immatics N.V. (IMTX) compare to its historical average?